Abstract
Anticoagulants and/or antiplatelet agents are used in the perioperative period for left atrial appendage occluder (LAAO) implantation to reduce the risk of stroke related to atrial fibrillation (AF) or thrombus from the device. However, the indication for LAAO is often a bleeding condition that may be exacerbated by these drugs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
